Heidelberg Pharma

Heidelberg Pharma is a Germany-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer.

Business Model:

Revenue: $6.6M

Employees: 51-200

Rankings

Detailed Heidelberg Pharma Information

Heidelberg Pharma was acquired by WILEX.
The acquisition happend on 2010-11-03.
Details of the transaction were not public

Acquirer

Geographic Data

Heidelberg Pharma headquarters map

Address: Schriesheimer Strasse 101

City: Ladenburg

State: bavaria

Zip: 68526

Country: DE

Financial Info

Stage:

post ipo equity

Raised Last:

$118M

Raised Total:

$121M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Heidelberg Pharma is a Germany-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer.

Contact Phone:

Contact Email:

Heidelberg Pharma went public on 11/17/2006 on the FRA

Listed Exchange:
FRA

IPO Date:
11/17/2006

Ticker Symbol:
WL6

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
4/2004 Series A $30.9M
2/2022 Post-IPO Equity $0 Huadong Medicine
Huadong Medicine
10/2006 Series B $20M
6/2021 Private Placement $24.2M
8/2022 Post-IPO Secondary 2 $89.3M Huadong Medicine
Huadong Investment
Huadong Medicine
Huadong Investment
8/2022 Post-IPO Equity 1 $15.9M Huadong Medicine
Huadong Medicine
4/2020 Private Placement $15.6M
11/2017 Post-IPO Equity $40.4M
2/2022 Post-IPO Equity $40.9M dievini Hopp BioTech holding GmbH & Co. KG
4/2020 Post-IPO Equity $0 dievini Hopp Biotech Holding
dievini Hopp Biotech Holding
dievini Hopp Biotech Holding
dievini Hopp Biotech Holding
1/2020 Post-IPO Equity $0 dievini Hopp Biotech Holding
dievini Hopp Biotech Holding
dievini Hopp Biotech Holding
dievini Hopp Biotech Holding
2/2022 Post-IPO Equity 1 $117.8M Huadong Medicine
Huadong Medicine
4/2020 Post-IPO Equity 1 $15.6M dievini Hopp Biotech Holding
dievini Hopp Biotech Holding
dievini Hopp Biotech Holding
dievini Hopp Biotech Holding
1/2020 Post-IPO Equity 1 $16.6M dievini Hopp Biotech Holding
dievini Hopp Biotech Holding
dievini Hopp Biotech Holding
dievini Hopp Biotech Holding
4/2004 Series A $30.9M
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research